ZA200105259B - Use of growth hormone secretagogues for stimulating or increasing appetite. - Google Patents
Use of growth hormone secretagogues for stimulating or increasing appetite.Info
- Publication number
- ZA200105259B ZA200105259B ZA200105259A ZA200105259A ZA200105259B ZA 200105259 B ZA200105259 B ZA 200105259B ZA 200105259 A ZA200105259 A ZA 200105259A ZA 200105259 A ZA200105259 A ZA 200105259A ZA 200105259 B ZA200105259 B ZA 200105259B
- Authority
- ZA
- South Africa
- Prior art keywords
- stimulating
- growth hormone
- hormone secretagogues
- increasing appetite
- appetite
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Biomedical Technology (AREA)
- Nutrition Science (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pathology (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Urology & Nephrology (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21497900P | 2000-06-29 | 2000-06-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200105259B true ZA200105259B (en) | 2003-01-02 |
Family
ID=22801146
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200105259A ZA200105259B (en) | 2000-06-29 | 2001-06-26 | Use of growth hormone secretagogues for stimulating or increasing appetite. |
Country Status (10)
Country | Link |
---|---|
US (1) | US20020086865A1 (ja) |
EP (1) | EP1181933A3 (ja) |
JP (1) | JP2002293743A (ja) |
KR (1) | KR20020002271A (ja) |
AU (1) | AU5410801A (ja) |
CA (1) | CA2351902A1 (ja) |
HU (1) | HUP0102696A3 (ja) |
IL (1) | IL143941A0 (ja) |
NZ (1) | NZ512664A (ja) |
ZA (1) | ZA200105259B (ja) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL144468A0 (en) * | 2000-07-27 | 2002-05-23 | Pfizer Prod Inc | Use of growth hormone secretagogues for improvement of functional health status |
US8637503B2 (en) | 2003-05-16 | 2014-01-28 | Board Of Regents, The University Of Texas System | Phenothiazine enantiomers as agents for the prevention of bone loss |
PE20080145A1 (es) * | 2006-03-21 | 2008-02-11 | Janssen Pharmaceutica Nv | Tetrahidro-pirimidoazepinas como moduladores de trpv1 |
CN101855218A (zh) | 2007-09-13 | 2010-10-06 | 康塞特医药品有限公司 | 氘化的儿茶酚和苯并[d][1,3]间二氧杂环戊烯及其衍生物的合成 |
EP2224929B1 (en) | 2007-12-17 | 2016-05-04 | Janssen Pharmaceutica, N.V. | Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of trpv1 |
ES2959427T3 (es) | 2012-09-27 | 2024-02-26 | Elanco Animal Health Incorporated | Composiciones farmacéuticas para el tratamiento de la inapetencia |
NZ733658A (en) | 2015-01-28 | 2018-07-27 | Aratana Therapeutics Inc | Compositions and methods for chronic use of a weight-gaining compound |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2095786A1 (en) * | 1992-05-08 | 1993-11-09 | Franco J. Vaccarino | Method of stimulating appetite |
US5721251A (en) * | 1993-12-10 | 1998-02-24 | Merck & Co., Inc. | Piperidine, pyrrolidine and hexahydro-1H-azepines promote release of growth hormone |
US5767124A (en) * | 1995-10-27 | 1998-06-16 | Merck & Co., Inc. | Polymorphic forms of a growth hormone secretagogue |
TW432073B (en) * | 1995-12-28 | 2001-05-01 | Pfizer | Pyrazolopyridine compounds |
AU2334097A (en) * | 1996-03-21 | 1997-10-10 | Merck & Co., Inc. | 4-spiroindoline piperidines promote release of growth hormone |
AU2722297A (en) * | 1996-04-03 | 1997-10-22 | Merck & Co., Inc. | Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone |
AU3220097A (en) * | 1996-05-22 | 1997-12-09 | Arch Development Corporation | Sleep quality improvement using a growth hormone secretagogue |
AU4342097A (en) * | 1996-09-13 | 1998-04-02 | Merck & Co., Inc. | Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone |
EP1001970B1 (en) * | 1997-06-25 | 2007-03-07 | Pfizer Inc. | Dipeptide derivatives as growth hormone secretagogues |
UA53716C2 (uk) * | 1997-06-25 | 2003-02-17 | Пфайзер Продактс Інк. | Тартратна сіль заміщеного дипептиду, спосіб її одержання, проміжні сполуки та спосіб їх одержання, фармацевтична композиція (варіанти), спосіб підвищення рівнів ендогенного гормону росту та спосіб лікування або профілактики захворювань (варіанти) |
US6358951B1 (en) * | 1998-08-21 | 2002-03-19 | Pfizer Inc. | Growth hormone secretagogues |
-
2001
- 2001-06-08 EP EP01305039A patent/EP1181933A3/en not_active Withdrawn
- 2001-06-21 IL IL14394101A patent/IL143941A0/xx unknown
- 2001-06-26 ZA ZA200105259A patent/ZA200105259B/xx unknown
- 2001-06-26 JP JP2001193024A patent/JP2002293743A/ja active Pending
- 2001-06-27 US US09/893,014 patent/US20020086865A1/en not_active Abandoned
- 2001-06-27 CA CA002351902A patent/CA2351902A1/en not_active Abandoned
- 2001-06-28 NZ NZ512664A patent/NZ512664A/xx unknown
- 2001-06-28 AU AU54108/01A patent/AU5410801A/en not_active Abandoned
- 2001-06-28 KR KR1020010037527A patent/KR20020002271A/ko active IP Right Grant
- 2001-06-28 HU HU0102696A patent/HUP0102696A3/hu unknown
Also Published As
Publication number | Publication date |
---|---|
HUP0102696A2 (hu) | 2002-04-29 |
NZ512664A (en) | 2002-11-26 |
AU5410801A (en) | 2002-01-03 |
EP1181933A3 (en) | 2002-04-10 |
HU0102696D0 (en) | 2001-08-28 |
US20020086865A1 (en) | 2002-07-04 |
JP2002293743A (ja) | 2002-10-09 |
EP1181933A2 (en) | 2002-02-27 |
CA2351902A1 (en) | 2001-12-29 |
KR20020002271A (ko) | 2002-01-09 |
IL143941A0 (en) | 2002-04-21 |
HUP0102696A3 (en) | 2004-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR19C1044I2 (fr) | Secretagogues des hormones de croissance | |
HUP0102272A3 (en) | For stimulating g astrointestinal motility use of growth hormone secretagogue | |
AU2002342653A8 (en) | Modified growth hormone | |
IL161865A (en) | System for the stimulation of hair growth | |
HK1051690A1 (en) | Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamidederivatives for the treatment of pain. | |
HUP0103072A3 (en) | Use of growth hormone secretagogues | |
ZA200105293B (en) | Use of growth hormone secretagogues for treatment of physical performance decline. | |
ZA200207677B (en) | Methods of treatment and kits comprising a growth hormone secretagogue. | |
IL147253A0 (en) | Growth hormone formulations | |
IL132625A0 (en) | Composition for inducing hair growth | |
IL144350A0 (en) | Growth hormone secretagogues | |
ZA997227B (en) | Process and intermediates for growth hormone secretagogues. | |
HK1051692A1 (en) | Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain. | |
ZA200105259B (en) | Use of growth hormone secretagogues for stimulating or increasing appetite. | |
HUP0402334A3 (en) | Modified human growth hormone | |
GB0106565D0 (en) | Growth hormone treatment | |
ZA200203069B (en) | Peptides for treatment of erectile dysfunction. | |
GB9904252D0 (en) | Composition for the treatment of pain | |
IL142480A0 (en) | Tissue growth stimulating system | |
ZA200000771B (en) | Homeopathic preparations of purified growth hormone. | |
HK1056555A1 (en) | Growth hormone secretagogues | |
GB0208120D0 (en) | Growth hormone secretagogues | |
GB0208119D0 (en) | Growth Hormone Secretagogues | |
GB0208116D0 (en) | Growth hormone secretagogues | |
GB0208117D0 (en) | Growth hormone secretagogues |